Episodes 1-15 of 23
No Patient Left Behind! Advancing CKD-Associated Pruritus Care
CME/CENo Patient Left Behind! Advancing CKD-Associated Pruritus Care
A Clear Horizon in Plaque Psoriasis: Exploring the Role of Investigational Oral Therapies
CME/CEA Clear Horizon in Plaque Psoriasis: Exploring the Role of Investigational Oral Therapies
Patient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
CME/CEPatient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
Finally, I Can Take a Break from My Itch! Optimizing CKD-aP Treatment
CME/CEFinally, I Can Take a Break from My Itch! Optimizing CKD-aP Treatment
Current Experiences in Identifying and Treating Itch in Patients on Hemodialysis
CME/CECurrent Experiences in Identifying and Treating Itch in Patients on Hemodialysis
Unveiling the Latest Advancements in CKD-Associated Pruritus Care
CME/CEUnveiling the Latest Advancements in CKD-Associated Pruritus Care
Managing Symptom Clusters in Patients on Hemodialysis With CKD-aP
CME/CEManaging Symptom Clusters in Patients on Hemodialysis With CKD-aP
What Dermatologists & Surgeons Need To Know: Adjuvant Treatment for Resectable Stage II Melanoma
MinuteCE®What Dermatologists & Surgeons Need To Know: Adjuvant Treatment for Resectable Stage II Melanoma
Optimizing Resectable Melanoma Outcomes Through Multidisciplinary Care and Multimodal Treatment Strategies
MinuteCE®Optimizing Resectable Melanoma Outcomes Through Multidisciplinary Care and Multimodal Treatment Strategies
Case Consult: Adjuvant Therapy Following Localized Treatment for Stage III Melanoma
MinuteCE®Case Consult: Adjuvant Therapy Following Localized Treatment for Stage III Melanoma
Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma
MinuteCE®Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma
What Dermatologists & Surgeons Need To Know: Adjuvant Treatment for Resectable Stage III/IV Melanoma
MinuteCE®What Dermatologists & Surgeons Need To Know: Adjuvant Treatment for Resectable Stage III/IV Melanoma
Navigating Adjuvant ICI Treatment in Stage II Melanoma: A Patient Case Presentation
MinuteCE®Navigating Adjuvant ICI Treatment in Stage II Melanoma: A Patient Case Presentation
Getting to the Root of CKD-Associated Pruritus: Questions From the Field
CME/CEGetting to the Root of CKD-Associated Pruritus: Questions From the Field
